American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws—2022 update
SL Ruggiero, TB Dodson, T Aghaloo… - Journal of oral and …, 2022 - Elsevier
Strategies for management of patients with, or at risk for, medication-related osteonecrosis of
the jaws (MRONJ)–formerly referred to as bisphosphonate-related osteonecrosis of the jaws …
the jaws (MRONJ)–formerly referred to as bisphosphonate-related osteonecrosis of the jaws …
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
ZL Liu, HH Chen, LL Zheng, LP Sun… - Signal transduction and …, 2023 - nature.com
Angiogenesis, the formation of new blood vessels, is a complex and dynamic process
regulated by various pro-and anti-angiogenic molecules, which plays a crucial role in tumor …
regulated by various pro-and anti-angiogenic molecules, which plays a crucial role in tumor …
Wnt and PI3K/Akt/mTOR survival pathways as therapeutic targets in glioblastoma
A Barzegar Behrooz, Z Talaie, F Jusheghani… - International journal of …, 2022 - mdpi.com
Glioblastoma (GBM) is a devastating type of brain tumor, and current therapeutic treatments,
including surgery, chemotherapy, and radiation, are palliative at best. The design of effective …
including surgery, chemotherapy, and radiation, are palliative at best. The design of effective …
Mast cells as sources of cytokines, chemokines, and growth factors
Mast cells are hematopoietic cells that reside in virtually all vascularized tissues and that
represent potential sources of a wide variety of biologically active secreted products …
represent potential sources of a wide variety of biologically active secreted products …
Stimuli-responsive nano-architecture drug-delivery systems to solid tumor micromilieu: past, present, and future perspectives
The microenvironment characteristics of solid tumors, renowned as barriers that harshly
impeded many drug-delivery approaches, were precisely studied, investigated, categorized …
impeded many drug-delivery approaches, were precisely studied, investigated, categorized …
[HTML][HTML] FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis
M Katoh - International journal of molecular medicine, 2016 - spandidos-publications.com
Abstract Fibroblast growth factor (FGF) 2, FGF4, FGF7 and FGF20 are representative
paracrine FGFs binding to heparan-sulfate proteoglycan and fibroblast growth factor …
paracrine FGFs binding to heparan-sulfate proteoglycan and fibroblast growth factor …
The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors
H Zalpoor, F Aziziyan, M Liaghat, M Bakhtiyari… - Cell Communication and …, 2022 - Springer
Innate and adaptive immune cells patrol and survey throughout the human body and
sometimes reside in the tumor microenvironment (TME) with a variety of cell types and …
sometimes reside in the tumor microenvironment (TME) with a variety of cell types and …
The great escape; the hallmarks of resistance to antiangiogenic therapy
JR Van Beijnum, P Nowak-Sliwinska… - Pharmacological …, 2015 - ASPET
The concept of antiangiogenic therapy in cancer treatment has led to the approval of
different agents, most of them targeting the well known vascular endothelial growth factor …
different agents, most of them targeting the well known vascular endothelial growth factor …
Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications
Angiogenesis is the formation of new blood vessels from pre-existing vessels. It is a highly
regulated process as determined by the interplay between pro-angiogenic and anti …
regulated process as determined by the interplay between pro-angiogenic and anti …
Soy and breast cancer: focus on angiogenesis
L Varinska, P Gal, G Mojzisova, L Mirossay… - International journal of …, 2015 - mdpi.com
Epidemiological studies have revealed that high consumption of soy products is associated
with low incidences of hormone-dependent cancers, including breast and prostate cancer …
with low incidences of hormone-dependent cancers, including breast and prostate cancer …